u/New_Book_9785

Spectral AI (NASDAQ:MDAI) reported quarterly losses of $(0.11) per share which missed the analyst consensus estimate of $(0.07) by 57.14 percent. This is a 200 percent decrease over earnings of $0.11 per share from the same period last year. The company reported quarterly sales of $3.991 million which missed the analyst consensus estimate of $4.125 million by 3.25 percent. This is a 40.50 percent decrease over sales of $6.707 million the same period last year.

Earnings Preview
Analysts estimate $Spectral AI (MDAI.US)$to post revenue of USD4.13M for 2026Q1, down 38.50% YoY;
EPS is estimated to be USD-0.07, swings to loss YoY.

Spectral AI was recognized for its DeepView System, an AI-driven, predictive diagnostic device and associated software platform that combines multispectral imaging with a proprietary AI algorithm to assess the healing potential of burn wounds. The DeepView System provides clinicians with an immediate, data-driven assessment of whether a burn wound will heal on its own or requires significant medical intervention, enabling earlier and more informed treatment decisions. Spectral AI submitted its De Novo clearance application for the DeepView System to the U.S. Food and Drug Administration in June 2025.